Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of vismodegib in advanced gastric adenocarcinoma with SMO overexpression
KCT0003175Phase 2Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vismodegib in gastric adenocarcinoma, sponsored by Samsung Medical Center. Started Feb 2017; status: recruiting.
02
Drugs
vismodegib
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on KCT0003175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003175.